Teoxane Debuts at ASDS 2024, Launching U.S. Dermocosmetics Line

Teoxane is delighted to announce its successful debut at the American Society for Dermatologic Surgery (ASDS) Congress in Orlando, marking an exciting new chapter as we officially launch our dermocosmetics line in the United States. This milestone reinforces Teoxane’s commitment to advancing aesthetic science and skincare innovation across global markets, with the U.S. as our newest focus.

Held in Orlando, ASDS 2024 provided an exceptional platform for Teoxane to connect with a community of talented dermatologic professionals, exchange insights, and showcase our cutting-edge approach to dermocosmetic science. Attendees had the opportunity to discover the latest innovations at our booth, where we introduced our advanced skincare formulations, developed with a commitment to quality and a scientific rigor inspired by the precision and standards that define our renowned filler portfolio.

Teoxane’s new dermocosmetics line, will soon be available for at-home use, bringing together advanced formulations tailored meeting the needs of skincare professionals and consumers alike. Built on our expertise in hyaluronic acid-based solutions, these products aim to raise the bar in skincare efficacy, offering U.S. consumers the opportunity to experience the trusted innovation that defines Teoxane.

Teoxane would like to thank everyone who visited us in Orlando and to the ASDS community for an inspiring experience. We look forward to many more exciting collaborations and developments as we expand our footprint in the U.S. and beyond.

For news and update please visit https://www.teoxane.us/